$QETA
Quetta Acquisition Corp

2023 Q4 Form 10-Q Financial Statement

#000182912623007424 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $43.09K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $121.1K $0.00 $0.00
YoY Change
Operating Profit
YoY Change
Interest Expense $823.3K $2.950K $740.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $702.2K $2.950K $740.00
YoY Change
Income Tax $170.7K
% Of Pretax Income 24.3%
Net Earnings $531.5K $2.949K $737.00
YoY Change 0.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.06 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 8.947M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $610.2K $262.7K
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $108.2K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $718.4K $262.7K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $70.51M
YoY Change
Other Assets $151.3K
YoY Change
Total Long-Term Assets $70.51M $151.3K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $718.4K $262.7K
Total Long-Term Assets $70.51M $151.3K
Total Assets $71.22M $413.9K $410.0K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.25K
YoY Change
Accrued Expenses $260.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $300.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $232.0K $385.3K $385.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.415M
YoY Change
Total Long-Term Liabilities $2.415M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $232.0K $385.3K $385.0K
Total Long-Term Liabilities $2.415M $0.00
Total Liabilities $2.647M $385.3K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$1.744M $3.686K
YoY Change
Common Stock $204.00 $172.00 $172.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $68.58M $28.69K $25.74K
YoY Change
Total Liabilities & Shareholders Equity $71.22M $413.9K $410.0K
YoY Change

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $531.5K $2.949K $737.00
YoY Change 0.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$161.2K $3.690K $737.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$69.69M
YoY Change
Cash From Investing Activities -$69.69M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 70.20M 259.0K $292.4K
YoY Change
NET CHANGE
Cash From Operating Activities -161.2K 3.690K $737.00
Cash From Investing Activities -69.69M
Cash From Financing Activities 70.20M 259.0K $292.4K
Net Change In Cash 347.5K 262.7K $293.1K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$161.2K $3.690K $737.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001978528
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41832
dei Entity Registrant Name
EntityRegistrantName
Quetta Acquisition Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
93-1358026
dei Entity Address Address Line1
EntityAddressAddressLine1
1185 Avenue of the Americas
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 301
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
612-1400
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8947045 shares
CY2023Q3 us-gaap Cash
Cash
262658 usd
CY2023Q2 us-gaap Cash
Cash
314700 usd
CY2023Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
151288 usd
CY2023Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
95300 usd
CY2023Q3 us-gaap Assets
Assets
413946 usd
CY2023Q2 us-gaap Assets
Assets
410000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
260 usd
CY2023Q3 QETAU Due To Related Party
DueToRelatedParty
85000 usd
CY2023Q2 QETAU Due To Related Party
DueToRelatedParty
85000 usd
CY2023Q3 QETAU Promissory Note Related Party
PromissoryNoteRelatedParty
300000 usd
CY2023Q2 QETAU Promissory Note Related Party
PromissoryNoteRelatedParty
300000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
385260 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
385000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1725000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1725000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1725000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1725000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
172 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
172 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24828 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24828 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3686 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
28686 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
25000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
413946 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
410000 usd
CY2022Q3 us-gaap Interest Income Operating
InterestIncomeOperating
2949 usd
us-gaap Interest Income Operating
InterestIncomeOperating
3686 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2949 usd
us-gaap Net Income Loss
NetIncomeLoss
3686 usd
CY2022Q3 QETAU Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
1500000 shares
QETAU Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
1500000 shares
CY2022Q3 QETAU Basic And Diluted Net Loss Per Share
BasicAndDilutedNetLossPerShare
0.00
QETAU Basic And Diluted Net Loss Per Share
BasicAndDilutedNetLossPerShare
0.00
CY2023Q2 QETAU Founder Shares Issued To Initial Stockholders
FounderSharesIssuedToInitialStockholders
25000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
737 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
25737 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
2949 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
28686 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3686 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3686 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
300000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
25000 usd
QETAU Payment Of Offering Costs
PaymentOfOfferingCosts
66028 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
258972 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
262658 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
262658 usd
QETAU Deferred Offering Costs Paid By Related Party
DeferredOfferingCostsPaidByRelatedParty
85000 usd
QETAU Deferred Offering Costs In Accrued Offering Costs And Expenses
DeferredOfferingCostsInAccruedOfferingCostsAndExpenses
260 usd
CY2023Q3 QETAU Percentage Of Amount Of Trust Assets Of Target Company Excluding Underwriting Commission Working Capital And Taxes
PercentageOfAmountOfTrustAssetsOfTargetCompanyExcludingUnderwritingCommissionWorkingCapitalAndTaxes
0.80 pure
CY2023Q3 QETAU Net Tangible Assets
NetTangibleAssets
5000001 usd
CY2023Q3 QETAU Percentage Of Public Shareholding To Be Redeemed In Case Of Non Occurrence Of Business Combination
PercentageOfPublicShareholdingToBeRedeemedInCaseOfNonOccurrenceOfBusinessCombination
1 pure
CY2023Q3 us-gaap Deposits
Deposits
600000 usd
QETAU Aggregate Amount
AggregateAmount
1200000 usd
CY2023Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
10.10
CY2023Q3 us-gaap Cash
Cash
262658 usd
CY2023Q3 QETAU Working Capital Deficit
WorkingCapitalDeficit
122602 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zPRf21INfD2a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_860_zwp0OuWNOURd">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing these financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q3 us-gaap Cash
Cash
262658 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
225000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zw5Ons57B1C2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86C_zBuwipq4rLHh">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_904_eus-gaap--FederalDepositInsuranceCorporationPremiumExpense_c20230501__20230930_z3Wxg56Qvx94" title="Federal depository insurance coverage">250,000</span>. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2023Q3 QETAU Founder Shares Issued
FounderSharesIssued
1725000 shares
CY2023Q3 QETAU Founder Shares Outstanding
FounderSharesOutstanding
1725000 shares
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
225000 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
85000 usd
QETAU Transaction Costs
TransactionCosts
85000 usd
CY2023Q3 QETAU Due To Related Party
DueToRelatedParty
85000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
85000 usd
CY2023Q2 QETAU Promissory Note Related Party
PromissoryNoteRelatedParty
300000 usd
CY2023Q3 QETAU Promissory Note Related Party
PromissoryNoteRelatedParty
300000 usd
CY2023Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.00
CY2023Q3 QETAU Working Capital Loans
WorkingCapitalLoans
0 usd
us-gaap Payments For Fees
PaymentsForFees
10000 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
1000 usd
QETAU Over Allotment Option Vesting Period
OverAllotmentOptionVestingPeriod
P45D
CY2023Q3 QETAU Deferred Fee Percentage
DeferredFeePercentage
0.035 pure
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1725000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1725000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1725000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1725000 shares
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
225000 usd

Files In Submission

Name View Source Status
0001829126-23-007424-index-headers.html Edgar Link pending
0001829126-23-007424-index.html Edgar Link pending
0001829126-23-007424.txt Edgar Link pending
0001829126-23-007424-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qetau-20230930.xsd Edgar Link pending
quettaacquisition_10q.htm Edgar Link pending
quettaacquisition_ex31-1.htm Edgar Link pending
quettaacquisition_ex31-2.htm Edgar Link pending
quettaacquisition_ex32-1.htm Edgar Link pending
quettaacquisition_ex32-2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qetau-20230930_cal.xml Edgar Link unprocessable
qetau-20230930_def.xml Edgar Link unprocessable
qetau-20230930_lab.xml Edgar Link unprocessable
qetau-20230930_pre.xml Edgar Link unprocessable
quettaacquisition_10q_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending